What is the main business of PZU Lab?

The main business activity of PZU Lab focuses on other engineering activities and related technical consultancy.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 13, 2011.

Where is the headquarters located?

The headquarters is located at: Rondo Ignacego Daszyńskiego 4, 00-843 Warszawa.

What is the share capital?

The share capital of the company is PLN 260,000 (approx. $70,232).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $3,342,942 in 2025, which is an increase of 20.1% compared to 2024.

Yes, the company recorded a net profit of $260,001 in 2025, meaning the company decreased its profit by 41.0%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $2,531,223 in 2025, representing 84% of all operating expenses.

PZU LabS.A.

Other engineering activities and related technical consultancy

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2011-09-13

Share capital

260 000,00 PLN

Activity description

Pzu Lab is a company that specializes in risk management and technical safety, providing support to businesses in safe enterprise management, minimizing financial losses from emergencies, and enhancing their reputation as a trusted partner. They offer a range of advisory and training services, as well as innovative technology solutions tailored to the specific needs of enterprises. Pzu Lab collaborates closely with company management to help them understand and address the risks their businesses face.

Registered address

Rondo Ignacego Daszyńskiego 4, 00-843 Warszawa, Poland

Website

pzu.pl

Phone

Social media

Electronic delivery address

AE:PL-62047-36276-JEDEH-33

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 3.34mMedianUSD 141.02kAverageUSD 2.17m

Net profit

This companyUSD 260.00kMedianUSD 13.29kAverageUSD 89.22k

Operating costs

This companyUSD 3.02mMedianUSD 101.91kAverageUSD 1.97m

Assets

This companyUSD 1.78mMedianUSD 96.95kAverageUSD 2.08m

Industry

Bank accounts

Registered as a VAT taxpayer on 2017-07-01. Active

Bank Millennium
72 1160 2202 0000 0001 9419 7970
PKO Bank Polski
72 1020 1026 0000 1402 0299 1404

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,687$1,687	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,457$3,457	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$2,951$2,951	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Trademarks

PZU Lab holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2017.

Mark	Number	Classes	Status	Protected until
PZU LAB	Z.516076	41, 42	Protected	Jul 15, 2030
pzu lab approved(word)	Z.480592	16, 35, 36, 41, 42, 45	Protected	Dec 27, 2027

Mark	Protected until
PZU LAB	Jul 15, 2030
pzu lab approved(word)	Dec 27, 2027

Authorized Representatives

Dariusz Piotr Gołębiewski – President of the Management Board

Marcin Grzegorz Ogniewski – Vice President of the Management Board

Wojciech Okrzeja – Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy, are authorised to make declarations of will and sign on behalf of the company.

Supervisory board

Agata Anna Bednarczyk – Supervisory Board Member

Małgorzata Śledziewska – Supervisory Board Member

Marek Zbigniew Wilczewski – Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Powszechny Zakład Ubezpieczeń S.A.	26,000	$70,232.31	100%

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	Fib.Codesp. z o.o.	$480,049.82	fibcode.com
	Sowixsp. z o.o.	$460,149.52	sowix.pl

Change history

Date	Event
2025-12-11	PKD change (Removed: 61.90.Z, 62.09.Z, 71.12.Z, 71.20.B, 72.19.Z, 74.90.Z; Added: 46.64.Z, 47.91.Z, 71.12.B, 71.20.C, 72.10.Z, 74.99.Z)
2024-01-30	PKD change (Removed: 72.20.Z, 85.59.B, 85.60.Z, 96.09.Z; Added: 33.20.Z, 61.90.Z, 62.09.Z, 84.25.Z)
2022-12-01	Address change (Ogrodowa 58, 00-876, Warszawa → Rondo Ignacego Daszyńskiego 4, 00-843, Warszawa)
2017-11-06	Share capital change (100,000.00 PLN → 260,000.00 PLN)
2017-11-06	Name change (Omicron → Pzu Lab)

FAQ

Last updated: 2026-06-16